
Overview
Chanhaeng Rhee is an Endocrinologist in Honolulu, Hawaii. Dr. Rhee and is rated as an Experienced provider by MediFind in the treatment of Jaundice. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Diabetic Neuropathy, and Diabetic Nephropathy.
His clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Cigna
- Blue Cross Blue Shield
- HMSA
- Alliant Health
- Oscar
- Humana
Locations
550 S Beretania St, Suite 202, Honolulu, HI 96813
Additional Areas of Focus
Dr. Rhee has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Type 1 Diabetes (T1D)
- Type 2 Diabetes (T2D)
- Advanced
- Diabetic Nephropathy
- Diabetic Neuropathy
- Diabetic Retinopathy
- Maturity Onset Diabetes of the Young
- Experienced
- Addison's Disease
- Anaplastic Thyroid Cancer
- Cushing's disease
- Diabetic Hyperglycemic Hyperosmolar Syndrome
- Eunuchoidism Familial Hypogonadotropic
- Follicular Thyroid Cancer